Home
About
Overview
Sharing Data
ORCID
Help
History (18)
Adult
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study.
Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic.
Role of MetMAb (OA-5D5) in c-MET active lung malignancies.
MET as a drug target.
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MET as a drug target.
MET as a drug target. Clin Adv Hematol Oncol. 2015 Jun; 13(6):351-3.
View in:
PubMed
subject areas
Antineoplastic Agents
Clinical Trials as Topic
Humans
Neoplasms
Proto-Oncogene Proteins c-met
authors with profiles
Ravi Salgia